Evofem Biosciences Inc (EVFM)

Evofem Biosciences (EVFM) Financial Statements


Evofem Biosciences Financial Overview

Evofem Biosciences's market cap is currently ―. The company's EPS TTM is $-12.384; its P/E ratio is >-0.01; Evofem Biosciences is scheduled to report earnings on May 10, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 6.37M$ 6.03M$ 4.25M$ 3.57M$ 1.71M
Gross Profit$ 4.69M$ 4.75M$ 3.19M$ 1.81M$ 757.00K
EBIT$ -18.72M$ -24.42M$ -28.93M$ -37.42M$ -43.37M
EBITDA$ -18.47M$ -24.17M$ -28.66M$ -37.13M$ -43.10M
Net Income Common Stockholders$ 89.51M$ -124.07M$ -31.97M$ -52.60M$ -74.06M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 7.75M$ 19.89M$ 2.76M$ 7.73M$ 14.86M
Total Assets$ 42.28M$ 53.47M$ 34.57M$ 42.51M$ 67.43M
Total Debt$ 83.75M$ 125.74M$ 120.36M$ 115.68M$ 102.61M
Net Debt$ 76.00M$ 105.85M$ 117.60M$ 107.95M$ 87.76M
Total Liabilities$ 120.33M$ 269.47M$ 162.67M$ 142.09M$ 126.25M
Stockholders Equity$ -78.04M$ -216.00M$ -128.10M$ -99.58M$ -58.83M
Cash Flow-
Free Cash Flow$ -16.37M$ -26.83M$ -20.98M$ -21.32M$ -37.96M
Operating Cash Flow$ -16.30M$ -26.66M$ -20.92M$ -21.27M$ -37.37M
Investing Cash Flow$ -70.00K$ -170.00K$ -66.00K$ -53.00K$ -597.00K
Financing Cash Flow$ 3.95M$ 41.36M$ 15.13M$ 9.87M$ 16.00K
Currency in USD

Evofem Biosciences Earnings and Revenue History

Evofem Biosciences Debt to Assets

Evofem Biosciences Cash Flow

Evofem Biosciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis